Nucleoside Analogue Therapy Following One-Year Course of Hepatitis B Immunoglobulin in Preventing Hepatitis B Virus Reactivation After Living Donor Liver Transplantation
Tohoku Journal of Experimental Medicine - Japan
doi 10.1620/tjem.222.275
Full Text
Open PDFAbstract
Available in full text
Date
January 1, 2010
Authors
Publisher
Tohoku University Medical Press